Clinical Trial Update: Ursodeoxycholic Acid as add-on Therapy in Type 2 Diabetes Mellitus [Phase 2, Phase 3]

View source ↗

Summary

A phase 2/3 clinical trial evaluating ursodeoxycholic acid as add-on therapy for type 2 diabetes mellitus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Ursodeoxycholic acid (ursodeoxycholic acid)

Snippet

Sponsor: Tanta University | Conditions: Diabetes Mellitus, Type 2 | Phase 2, Phase 3 | Status: UNKNOWN